Abstract-Mitral valve prolapse (MVP) is one subtype of mitral valve (MV) disease and is often characterized by enlarged leaflets that are thickened and have disrupted collagen architecture. The increased surface area of myxomatous leaflets with MVP leads to mitral regurgitation, and there is need for percutaneous treatment options that avoid open-chest surgery. Radiofrequency (RF) ablation is one potential therapy in which resistive heating can be used to reduce leaflet size via collagen contracture. One challenge of using RF ablation to percutaneously treat MVP is maintaining contact between the RF ablation catheter tip and a functioning MV leaflet. To meet this challenge, we have developed a RF ablation catheter with a cryogenic anchor for attachment to leaflets in order to apply RF ablation. We demonstrate the effectiveness of the dual-energy catheter in vitro by examining changes in leaflet biaxial compliance, thermal distribution with infrared (IR) imaging, and cryogenic anchor strength. We report that 1250 J of RF energy with cryo-anchoring reduced the determinant of the deformation gradient tensor at systolic loading by 23%. IR imaging revealed distinct regions of cryo-anchoring and tissue ablation, demonstrating that the two modalities do not counteract one another. Finally, cryogenic anchor strength to the leaflet was reduced but still robust during the application of RF energy. These results indicate that a catheter having combined RF ablation and cryo-anchoring provides a novel percutaneous treatment strategy for MVP and may also be useful for other percutaneous procedures where anchored ablation would provide more precise spatial control.
INTRODUCTION
Mitral valve (MV) disease is the most common form of heart valve disease, occurring in approximately 2% of the population and resulting in 43,000 open-chest surgical procedures every year. 8 MV prolapse (MVP) is one subtype of the disease and is characterized by superior displacement of one or both leaflets into the left atrium, resulting in mitral regurgitation (MR). One common cause of MVP is myxomatous MV disease, which is characterized by thickened and enlarged leaflets, disrupted and compromised collagen architecture, and an increased quantity of proteoglycans. The etiology is unknown at this time. 21 The current gold standard to correct MVP is openchest surgical valve repair or replacement, which is highly undesirable for elderly patients. In the past decade, percutaneous treatment of MV disease has received a great deal of interest. 4, 5, 18 Specifically, the MitraClip 3,7 (Abbott Laboratories) is one technique undergoing clinical trials and is a percutaneous variation of the Alfieri edge-to-edge technique, 2 which creates a double orifice valve by fixing together the free edges of the anterior and posterior leaflets. The MitraClip has been assessed in the EVEREST II clinical trial and was found to have a 55% rate of primary end point efficacy at 12 months, which included freedom from grade 3+ or 4+ MR, freedom from death, and freedom from surgery for MV dysfunction. 6 Additionally, major adverse clinical events occurred at a rate of only 15% in the percutaneous-repair group at 30 days, compared with 48% of patients in the surgery group. While the reduced complication rate indicates that percutaneous strategies may represent a safer alternative to open-chest surgery, the end point efficacy indicates that there remains room for improvement. Therefore, we believe that there is a need for additional percutaneous options to treat MVP that preserve the MV apparatus and restore normal fluid mechanics.
One potential percutaneous treatment strategy for myxomatous MVP is the use of radiofrequency (RF) ablation to reduce MV leaflet size to reduce MR. Due to the increased size of myxomatous leaflets, they fail to properly coapt during systole, and this redundancy of excess leaflet tissue provides an opening for regurgitant flow. By reducing leaflet size, coaptation could improve and thereby reduce MR. RF ablation generates thermal lesions via resistive heating of tissue and is dependent on power, interface temperature, electrode size, and contact pressure. 12 For our purposes, the target of RF ablation is the disrupted or distended collagen architecture of the MV leaflets; collagen has been shown to denature and contract when heated to temperatures greater than 65°C. 24 Using biaxial mechanical testing, we have demonstrated that RF ablation effectively reduces MV leaflet geometry and alters biomechanical compliance in vitro. 20 Previously, RF ablation treatment of myxomatous MVP has been shown to be feasible in a surgical canine model in which an acute in vivo study was performed on beagles with MR under open-heart surgery, demonstrating a mean 49.6% reduction in post-ablation MR. 25 Additionally, a chronic in vivo study was performed on healthy beagles to assess the ability to apply RF energy percutaneously and to assess the durability of the procedure at 6 weeks. An average of 22 applications of RF ablation for 60 s at an average power of 58 W was required to induce structural alteration of the leaflets, and alterations were found to be durable 6 weeks later. For comparison, four applications of RF ablation for approximately 40 s at a power of 16 W were required to reduce MR in the acute in vivo study. These results indicate that: (1) RF ablation is a feasible technique for reducing MR, (2) the alterations due to RF ablation remain durable, although the effects on valvular tissues after 6 weeks are not known, and (3) more RF energy is required to induce structural alteration of MV leaflets when applying RF energy percutaneously due to heat dissipation to the surrounding blood. The primary explanation for the increased number of RF ablation applications in the percutaneous case is that poor contact exists between the RF electrode on the catheter tip and the surface of the moving MV leaflet. The result of this is that RF energy may have been delivered entirely into the blood or into the surrounding myocardium. Therefore, to reduce misguided application of RF energy and improve delivery directly into the MV leaflet tissue, a stability technique is needed to physically anchor the catheter tip to the leaflet surface.
One possible method of maintaining contact between the RF ablation catheter tip and the moving MV leaflet is using a catheter with a cryogenically cooled anchoring element, or a cryo-anchor. This technique works similarly to cryo-ablation, which uses pressurized liquid nitrogen to cool a catheter tip to temperatures as low as 280°C and has been utilized since 1999 as an alternative for treating cardiac arrhythmias.
14 Cryo-ablation is generally less destructive than RF ablation and has previously been shown to maintain the extracellular collagen matrix, without collagen denaturation or contracture related to thermal effects. 23 Further, permanent damage to myocardial tissues due to cryo-ablation has been shown to occur only at temperatures below 230°C, 12 making this temperature an excellent target for use in a cryoanchor. While cryo-anchoring is used here as a method to adhere to MV leaflets, it may have broader applications in use as a stability technique for a variety of percutaneous procedures. For example, treatments that require the use of RF ablation in dynamic environments, such as treatment of cardiac arrhythmias, could potentially benefit from using cryo-anchoring for catheter stability.
The purpose of this study was to determine the feasibility of using cryo-anchoring and RF ablation on the same catheter tip and to quantify the biomechanical and thermodynamic effects of RF ablation on porcine MV leaflets. We hypothesized that an RF ablation catheter that utilizes a cryo-anchor will effectively adhere to and alter MV leaflet geometry and compliance, reducing MV leaflet size at maximum systolic load. To test this hypothesis, we developed a catheter prototype containing both a cryo-anchor for attachment and stability and an RF electrode for ablation. To investigate the effects of using cryogenic temperatures and resistive heating in close proximity, we quantified changes in biaxial mechanical compliance of MV leaflets and used infrared (IR) thermal imaging to discern distinct thermal regions within the tissue. We also quantified the anchor strength of the cryo-anchor both with and without RF ablation. These data support our hypothesis that simultaneous cryoanchoring and RF ablation effectively reduces MV leaflet size and compliance, while further demonstrating that cryo-anchoring and RF ablation can function effectively in close proximity on a single catheter tip.
MATERIALS AND METHODS

Catheter Prototype
A 4 mm (12 French) diameter catheter prototype was developed containing both a cryogenically cooled anchor (cryo-anchor) and an RF ablation electrode (Figs. 1a and 1b) . The cryo-anchor and RF electrode reside in-line on the catheter shaft and are separated by a 1 mm spacer, with the cryo-anchor on the most distal point of the catheter. Both the cryo-anchor and RF electrode are constructed out of hollow copper rod and are approximately 1.9 mm in length. The cryo-anchor is thermally connected via a solder joint to an inner copper rod containing a lumen which allows liquid nitrogen delivery. Teflon is used to insulate the RF electrode from the cryo-anchor and inner copper rod, and a thermocouple attached to the outer surface of the cryo-anchor records the temperature at the anchortissue interface. RF ablation is performed with an Osypka HAT 300 generator, capable of delivering a 500 kHz electrical signal at powers of up to 50 W to the RF electrode on the catheter tip. Liquid nitrogen is contained inside a handheld canister (Cry-Ac, Brymill Cryogenic Systems) and delivered to the catheter tip under vacuum by an inner lumen housed inside the catheter.
Control of RF ablation and liquid nitrogen delivery is performed via custom built control electronics for synchronization and repeatability (Fig. 1c) . Liquid nitrogen flow control is binary, and a servo motor is used to switch flow on and off. The sequence used for liquid nitrogen flow was developed to anchor the catheter tip to the tissue sample prior to RF ablation and to maintain anchoring throughout the ablation (Fig. 1d) . Control of the RF generator was performed by interfacing with the footswitch port on the generator, with air flow controlled by a solenoid valve and control electronics. For each ablation, one of three RF protocols was utilized at 25, 45, or 50 W of power for 15, 20, or 30 s, respectively (Fig. 1d) . Due to the time required for the RF generator to increase the power to the desired set-point (~3 s), the total energy output was lower than that produced by the product of time and power (Joules = W s). The final energy delivery to the tissue, as recorded by the generator for each of the 25, 45, and 50 W ablations, was 350, 850, and 1250 Joules (J), respectively.
Tissue Preparation
Healthy porcine MV leaflets were obtained from a local abattoir (Hampton Meat Processing, Hopkinsville, KY), excised on-site, and frozen in phosphate buffered saline (PBS) at 220°C until testing. Anterior leaflets were chosen for the biomechanical and thermal imaging studies due to their larger and more continuous surface area compared to posterior leaflets, although it is noted that posterior leaflets are more often affected by MVP. 5 The center portion of the leaflets were used and trimmed into rectangular sections ( Fig. 2a ) approximately 12 mm in the radial direction and 15 mm in the circumferential direction. The center portion was used as it experiences the most homogenous strains during MV closure. 22 For the anchor strength study, posterior leaflets were used for testing.
Biaxial Mechanical Testing
Biomechanical analysis was performed using a custom-designed biaxial mechanical testing device (Fig. 2a) . 20 Samples were loaded in each direction up to a membrane tension comparable to that experienced by the leaflet during systole (120 mmHg % 90 N/m of membrane tension), and all testing was performed with samples fully submerged in PBS at 37°C. Prior to testing, each sample was pre-conditioned over ten loading cycles to 90 N/m with a 15 s rise time. Following pre-conditioning, a marker reference was recorded and used as the unloaded state. Samples were then tested for ten cycles with a 15 s rise time to 90 N/m in order to determine untreated compliance. Stressstrain behavior has been found to be independent of loading rate for cycles with rise times of up to 15 s, thus tissues were not loaded at physiologic rates. 10 After determining leaflet biomechanical properties, samples were loaded to 10 N/m and subjected to one of the following four treatments with the catheter prototype. In order to determine the biomechanical effects of the cryo-anchor alone, samples were kept in contact with the cryo-anchor for 30 s at approximately 220 to 230°C (n = 3). To test the combined effects of cryo-anchoring and RF ablation, tissues were subjected to one of three treatment groups (n = 5) as described earlier and shown in Fig. 1d . During treatment, the fluid level in the bath was lowered to just below the surface of the sample in order to ensure that maximal energy transfer was through the tissue. By performing treatment such that all RF energy must pass through the sample, the amount of RF energy required to invoke the recorded biomechanical changes can be determined. The alternative is to completely submerge leaflets during treatment, but this provides a very low resistive path to ground, which bypasses the target tissue via direct conduction through the PBS bath. Four ground electrodes were placed in the bath, approximately 13 cm away from the tissue, to complete the electrical circuit for RF ablation. Following treatment, samples were returned to their unloaded state, a new marker reference was recorded to determine changes in unloaded geometry, and samples were loaded for ten cycles to 90 N/m. All data reported is from the tenth loading cycle of each experiment.
All analysis of biaxial mechanical data was performed using MATLAB (Mathworks). Marker positions recorded just prior to loading were used to determine geometric changes of the unloaded tissues due to treatment with the catheter prototype. Unloaded marker area was calculated as the area enclosed by the polygon connecting the four markers. Additionally, the percent change in the determinant of the deformation gradient tensor, F (% change in det(F)) was used to provide a quantitative assessment of the biomechanical changes of the tissue at maximum systolic load. The determinant of F is the ratio of the deformed marker area to the marker area of the reference state, where:
! F 11 and F 22 represent the stretch ratios in the circumferential and radial directions, respectively, and j 1 and j 2 provide a measure of shear. det(F) was determined at 90 N/m before and after treatment, and the unloaded marker reference state recorded just after pre-conditioning was used for all calculations. Because the same marker reference state is used to determine F in both the untreated and treated conditions, % change in det(F) provides a direct comparison of systolic leaflet deformation before and after treatment. Therefore, we refer to % change in det(F) at 90 N/m as % change in areal systolic deformation. In addition to reporting changes in det(F) due to treatment, we also report % change in axial systolic deformations which are changes in F 11 and F 22 at 90 N/m. For a more complete description of the calculation of F from biaxial mechanical testing, see Humphrey. 13 
Infrared Thermal Imaging
Thermal imaging of simultaneous cryo-anchoring and RF ablation was performed using an IR camera (ThermoVision A20M, FLIR Systems) with a measurement range of 220 to 250°C and accuracy of ±2°C. Previous studies have used IR imaging to identify the lethal isotherm of RF lesions. 15, 26 Leaflets were imaged in a custom built bath, and the camera was placed below the bath for imaging of full thickness changes in temperature distribution (Fig. 2b ). An IR window (IR Material Window, Edmund Optics Inc.) was placed at the bottom of the bath to allow imaging through the bottom surface by allowing transmission of IR wavelengths. Prior to treatment, an image was taken of a calibration phantom to determine the x and y distance scales. Testing was performed in PBS at room temperature, and the fluid level was lowered to just below the top surface of the tissue to allow maximal energy transfer through the leaflet. Four ground electrodes were placed in the bath in a circular pattern, each approximately 13 cm from the center of the leaflet. During ablation, a non-conductive plate was placed over the leaflet in order to maintain contact of the entire leaflet surface with the IR window. This was done to ensure that the temperatures measured were of the leaflet itself and not the fluid between the leaflet and IR window. All samples were then treated using one of the ablation sequences in Fig. 1d (n = 3 for each of the 350, 850, and 1250 J sequences), and images of the treatment were recorded at 1 Hz beginning at the onset of RF ablation using ThermaCAM Researcher software and synchronized with the ablation sequence using the control electronics. Images were then analyzed in MATLAB to produce thermal contour plots of the tissue. Additionally, the area of tissue heated to >65°C was quantified in order to provide a measure of the extent of thermal contracture of the extracellular matrix collagen, and the tissue area <0°C was also quantified to provide an estimate of the attachment area of the catheter prototype.
Anchor Strength
In order to assess the anchor strength of the cryoanchor both with and without RF ablation, a submersible load cell was used (Model 31 Mid, Honeywell). Posterior MV leaflets were clamped onto the load cell assembly and completely submersed in PBS at 37°C (Fig. 2c ). Leaflets were completely submersed during treatment in order to test the anchor strength of the cryo-anchor in an environment that more closely mimics the in vivo case. The output from the load cell was amplified using a custom built amplifier circuit and read into LabView using a data acquisition card (NI 9205, National Instruments). Anchor strength was tested at one of two protocols (n = 5 for each protocol). For the ''Cryo Only'' protocol, liquid nitrogen was pumped under vacuum to the catheter tip continuously for 10 s, and the catheter was then immediately pulled from the leaflet surface until separation. To determine the loss of anchor strength resulting from application of RF energy, the ''RF + Cryo'' protocol consisted of 5 s of continuous liquid nitrogen delivery, followed by 10 s of RF ablation at 50 W with continuous liquid nitrogen delivery. The catheter was then pulled away from the leaflet surface until separation. In both cases, the maximum load during separation was recorded. Maximum load was converted to anchor strength by dividing the load by 0.12 cm 2 , the approximate area of the cryo-anchor in contact with the tissue.
Statistics
Data are presented as mean ± SE. To analyze significance of changes due to combined RF ablation and cryo-anchoring for the biomechanical and anchor strength studies, data were analyzed using a one way ANOVA (a = 0.05) for multiple pair wise comparison (Holm-Sidak method).
RESULTS
Tissue Geometry and Compliance
Prior to treatment, leaflets displayed a typical, anisotropic mechanical response to loading, 11 with the radial direction much more compliant than the circumferential direction (Figs. 3a and 3b ). This is due to collagen fibers being preferentially aligned in the circumferential direction. Following 30 s of cryoanchoring, MV leaflets experienced negligible changes in geometry and mechanical response (Fig. 3a) . However, after 1250 J of RF ablation with cryo-anchoring, leaflets underwent significant changes. In the circumferential direction, changes in systolic deformation were attributable primarily to shrinkage of the tissue, as indicated by a large shift in stretch ratio in the unloaded state (membrane tension = 0 N/m), while the radial direction underwent a decrease in systolic deformation with little geometric changes.
There was a consistent trend of decreasing marker area with increasing RF energy (Fig. 3c) , due primarily to decreases in length in the circumferential direction (Fig. 3d) . Change in systolic deformation was analyzed at maximum load, 90 N/m (Figs. 3e and 3f) , with all deformations referenced to the marker reference state recorded just after pre-conditioning. Similarly to geometric changes, the areal systolic deformation decreased with increasing RF energy (Fig. 3e) , due primarily to shrinkage in the circumferential direction. Additionally, there was a consistent trend of decreasing axial systolic deformation in both the circumferential and radial directions with increasing RF energy (Fig. 3f) , although the changes in the radial direction were not significant.
Temperature Distribution
Leaflet tissue >65°C was quantified to identify the area of the leaflet exposed to temperatures that cause thermal damage to collagen. The area >65°C was found to increase with increasing RF energy, from 0.51 ± 0.13 to 1.9 ± 0.13 cm 2 at energies of 350 and 1250 J, respectively (Fig. 4a) . The tissue area below 0°C was used to determine the degree of cryo-anchoring present during ablation and was approximately 0.14 ± 0.05 cm 2 at the end of the 1250 J ablations. For comparison, the area of the cryo-anchor in contact with the leaflet during the procedure is approximately 0.12 cm 2 . Thermal contours at the end of each treatment indicate distinct regions of cryo-anchoring and tissue ablation (Fig. 4b) . The thermal contour plots at the end of the 350 J treatment shows minimal tissue >65°C, while the majority of the leaflet tissue is >65°C in the 1250 J treatment.
Anchor Strength
Following cryo-anchoring for 10 s, anchor strength was found to be 1020 ± 23 kPa (Fig. 5) . As expected, application of RF ablation at 50 W for 10 s with cryoanchoring reduced the anchor strength significantly (p < 0.005) to 668 ± 79 kPa; however, the adherence is still robust.
DISCUSSION
We have previously shown that RF ablation directionally alters MV leaflet geometry and compliance. 20 The therapeutic effect of our percutaneous treatment strategy is to restore competence to diseased or prolapsed MV leaflets by reducing leaflet size, and therefore, displacement of leaflets into the atrium during systole. However, any device that aims to percutaneously treat MVP must do so in a highly dynamic mechanical environment. Additionally, due to the high rate of blood flow across the MV and the resulting potential for heat convection, application of RF energy must be performed with the RF electrode in direct contact with the target tissue. Thus, we have introduced cryo-anchoring as a means to potentially maintain direct catheter contact with a moving MV leaflet and to enhance stability during the procedure. During cryo-anchoring, tissue is cooled to <0°C, which interferes with the resistive heating that is the therapeutic mechanism behind RF ablation. However, due to the small size of MV leaflets, cryo-anchoring must be utilized in close proximity to the RF electrode. In this study, we demonstrate the effects of using two competing energy modalities and the feasibility of RF ablation performed with cryo-anchoring.
More RF Energy Required with Cryo-Anchoring
Biaxial mechanical data following treatment with the catheter prototype demonstrates that RF ablation remains a valid therapy, even with sub-freezing temperatures on the cryo-anchor in close proximity on the MV leaflet (Fig. 3) . To determine the extent to which cryo-anchoring reduces the biomechanical effects of RF ablation, we re-analyzed previous biaxial data from treatment with a commercially available RF catheter (7F, Blazer II, Boston Scientific) without cryoanchoring, 20 plotting the % change in areal systolic deformation alongside our data presented here (Fig. 6) . While RF ablation with cryo-anchoring altered unloaded MV leaflet geometry and deformation at systolic loading, it took significantly more energy vs. RF ablation alone to produce the same effect. Previous treatments using the commercially available RF catheter reduced areal systolic deformation by approximately 25% when 350 J of energy was applied at a power of 25 W. 20 In treatments utilizing cryo-anchoring, areal systolic deformation decreased by only 2.8 ± 0.6% under the same RF conditions. However, when 1250 J of energy was applied at a power of 50 W, our catheter prototype was able to produce changes similar to the commercially available catheter at 350 J. These results indicate that even though RF power must be increased significantly when cryo-anchoring is used, the catheter prototype can still achieve the same therapeutic effect.
Thermally-Related Collagen Contracture
RF ablation introduces both geometric and biomechanical changes in MV leaflets; specifically, changes in areal systolic deformation are primarily due to length changes in the circumferential direction (Fig. 3d) . This shortening of the collagen fibers in the circumferential direction is due to thermal rupture of heat-sensitive bonds and uncoiling of the collagen triple helix. This uncoiling of collagen fibers and transition from a crystalline state to a random coil is responsible for collagen shortening, and transmission electron microscopy of collagenous tissues treated with RF ablation show collagen fibrils that increase in average diameter with increasing RF power. 17 Additionally, aligned collagen fibers fuse together in the orthogonal directions after treatment with RF ablation, 16, 17 leading to modest changes seen in the radial direction here (Fig. 3d) . Therefore, the use of a cryo-anchor for stability during the RF ablation procedure reduces the therapeutic effect of RF energy, but this effect can be mitigated by increasing RF power.
Heat Distribution of RF Ablation with Cryo-Anchoring
In addition to determining biomechanical changes induced by RF ablation, we have analyzed the temperature distribution resulting from combined RF ablation with cryo-anchoring. Estimates for the onset of unwinding of the collagen triple helix vary and have been determined to be approximately 60°C in the bovine joint capsule 19 and 67.1°C in the bovine MV. -30 FIGURE 6. % Change in areal systolic deformation with RF ablation alone (black bars) 20 and RF + cryo-anchoring (gray bars), demonstrating that more RF energy is needed when cryo-anchoring is utilized to produce the same therapeutic effect as RF ablation alone.
Thus, we used 65°C as a threshold for permanent collagen denaturation and determined the area of tissue heated above this temperature. IR imaging reveals that while there is a distinct region of cryo-anchoring present through the full thickness of the leaflet, which stays relatively consistent across all RF energies, heating due to RF ablation dominates the leaflet temperature distribution. As a result, full thickness temperatures <0°C are confined to an area slightly larger than the cryo-anchor attachment area. Because thermal damage to the collagen matrix forms the basis of mechanical damage, we hypothesized that the tissue area heated above 65°C would correlate with changes in areal systolic deformation (Fig. 7) . Indeed, this correlation is evident when % change in areal systolic deformation is plotted against tissue area above 65°C, demonstrating that biomechanical changes may be directly related to the amount of thermal tissue damage.
Cryo-Anchor Attachment to MV Leaflets
Testing of the anchor strength of the cryo-anchor revealed that this attachment is sufficient to maintain contact, even with RF ablation, with stationary MV leaflets. While there are currently no direct estimates for the anchor strength required to maintain attachment to the MV during the cardiac cycle, one estimate can be made based on the atrial pressure during MV opening. Because the proposed catheter treatment involves access to the MV via the left atrium, and the peak atrial pressure is a representation of the force required to open the MV, this is an estimate for the minimum attachment force required to maintain adherence. Peak atrial pressure in normally functioning hearts is typically below 20 mmHg, 9 or about 2.7 kPa. Thus, even if a much higher estimate for the atrial pressure is chosen, this value is considerably lower than the approximately 668 kPa of anchor strength recorded at 10 s of the 50 W RF ablation. Additionally, we speculate that cryo-anchoring and ablation of MV leaflets will occur with the MV kept partially open, with one leaflet kept anchored and the other moving freely. This may further reduce the force required to maintain cryo-anchoring.
Study Limitations
The data presented here indicate that RF ablation performed with cryo-anchoring alters MV leaflet geometry and deformation in vitro; however, there are several limitations to this study. First, all treatments were performed on stationary leaflets in vitro. While this ensures robust delivery of RF energy, it is not realistic, particularly with regards to the anchor strength studies. Further work must be performed to verify the feasibility of cryo-anchoring on moving MV leaflets, both in vitro and in vivo. Additionally, ablations in the biomechanical and thermal imaging studies were performed on leaflets with the saline bath lowered, such that the maximum amount of RF energy would penetrate the leaflets. This provides a much more accurate measurement of the total energy delivered to the leaflet, but the in vivo environment is much more dynamic. Due to convective blood flow, in vivo treatments will require additional or prolonged RF energy delivery in order to produce the same biomechanical alterations, as demonstrated in a feasibility study utilizing a canine model. 25 Finally, these studies were performed on healthy porcine MV leaflets. It is unknown how leaflets with MVP might respond to RF ablation, due to their disorganized collagen architecture.
Design Considerations for In Vivo Translation
In light of the results from this study and previous studies regarding RF ablation, we have identified several design considerations for in vivo translation of our combined RF ablation and cryo-anchoring catheter. First, we demonstrated in vitro that RF energy must be increased when used in conjunction with cryoanchoring in order to achieve a similar therapeutic effect of RF alone. Because our biaxial mechanical analysis was performed on leaflets treated while only partially submerged, heat dissipation will increase when treatment is performed in vivo, due to the surrounding hemodynamic environment. Thus, RF energy delivery will likely need to be increased in a similar manner and this will likely be accomplished by increasing either RF power or application time. Similarly, through placement in a dynamic hemodynamic environment and increases in application of RF energy, cryo-anchor strength may be reduced at the current liquid nitrogen delivery protocol, and liquid nitrogen delivery may need to be increased by increasing vacuum pressure and delivery time to compensate. Also, in order to decrease the amount of RF energy lost to the blood stream, RF electrode placement can be configured to allow for more direct delivery to the leaflets. One possible configuration is to replace the current, singular RF electrode, which encircles the entire 360°outer circumference of the catheter shaft, with three separate RF electrodes that are approximately 120°of the circumference and are insulated from each other. By having three separate electrodes, RF energy can be delivered to the electrode in direct contact with the leaflet, ensuring that the majority of RF energy enters the leaflet, as opposed to the bloodstream. These, and other potential modifications, will likely be necessary to translate this strategy into an integrated catheter that will be successful in vivo.
CONCLUSIONS
In this study, we demonstrate that RF ablation with a cryo-anchor may provide an alternative percutaneous treatment strategy for MVP. While it was previously shown that RF ablation alone reduces MV leaflet size, we have demonstrated the feasibility of cryo-anchoring as a stability technique for secure attachment of a catheter to a MV leaflet. Additionally, cryo-anchoring may have possible uses in other applications involving RF ablation or in more general percutaneous catheters as a mechanism to enhance stability and improve catheter contact in complex anatomies or hard-to-reach sites. Cryo-anchoring may be a particularly effective strategy in improving catheter stability during treatment of cardiac arrhythmias, given the dynamic environment of the heart. While we found here that cryo-anchoring reduces the effect of RF ablation, these effects can be mitigated by increasing RF power and duration. These in vitro results indicate that RF ablation with simultaneous cryo-anchoring reduces MV leaflet size and may be a viable clinical strategy for percutaneous treatment of myxomatous MVP.
